Avanzanite
Avanzanite is a biotech company in Amsterdam, Netherlands, founded in 2022. It has raised $37.0M across 1 round, most recently a $37.0M Series A in November 2025.
Avanzanite Bioscience B.V. | No One Left Behind
- Headquarters
- Amsterdam
- Founded
- 2022
- Business Model
- B2B
- Website
- avanzanite.com
- Total Funding
- $37.0M
- Last Round
- $37.0M Series ANov 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Avanzanite works to expand patient access to medicines for rare diseases in Europe. It supports emerging research-based biopharmaceutical partners by helping unlock revenue and growth potential from these medicines, connecting its work on patient access with the commercial growth of its biopharmaceutical partners.
Summary
It has raised $37.0M in total across 1 round, most recently a $37.0M Series A round in Nov 2025. Investors include MVM Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avanzanite"><img src="https://indexed.vc/api/badge/company/avanzanite" alt="Avanzanite on Indexed.vc" width="260" height="76" /></a>